Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 41Colonic Neoplasms 36Rectal Neoplasms 34Stomach Neoplasms 18Pancreatic Neoplasms 16Esophageal Neoplasms 11Neoplasm Metastasis 8Liver Neoplasms 8Adenocarcinoma Of Esophagus 8Carcinoma, Hepatocellular 6Esophageal Squamous Cell Carcinoma 5Gallbladder Neoplasms 3Bile Duct Neoplasms 3Recurrence 2Peritoneal Neoplasms 2Breast Neoplasms 2Biliary Tract Neoplasms 2Turcot syndrome 1Sarcopenia 1Sarcoglycanopathies 1Resectable Pancreatic Cancer 1Pancreatic Neuroendocrine Tumors (pNET) 1Oesophagogastric Cancer 1Neoplasms 1Neoplasm, Residual 1Microsatellite Instability 1Melanoma 1Malnutrition 1Lymphatic Metastasis 1Hepatoblastoma 1

Interventions

Gemcitabine 3folfirinox 2Cisplatin 2paricalcitol 1nimotuzumab 1Taxes 1Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Chemotherapy, Adjuvant 1Chemoradiotherapy, Adjuvant 1Albumin-Bound Paclitaxel 1Adjuvants, Immunologic 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Pancreatic Cancer × Chemotherapy, Adjuvant × Gastrointestinal × Clear all
NCT04737551 2021-02-04

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Shanghai Zhongshan Hospital

Unknown
400 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡